NGIO needs to get that S-1 put in and get the ball rolling for SEC approval and to let Dawson James to start their process to move forward.
One less headache for NGIO and another financial stream for the company as well. I am not sure why they are dragging their feet on this.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
-
-
-
-
-
-
-